The Rate of Progression to Polycythemia Vera or Essential Thrombocythemia in Patients with Erythrocytosis or Thrombocytosis

Annals of Internal Medicine

Volumn 139, Issue 6, 2003, Pages

  Ruggeri, Marco ^a   Tosetto, Alberto ^a   Frezzato, Maurizio ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROCYTOSIS; FEMALE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOPENIA; THROMBOCYTOSIS; ADOLESCENT; CROSS-SECTIONAL STUDY; FOLLOW UP; ITALY; MIDDLE AGED; POLYCYTHEMIA; PREVALENCE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; ITALY; MALE; MIDDLE AGED; PLATELET COUNT; POLYCYTHEMIA; POLYCYTHEMIA VERA; PREVALENCE; RISK FACTORS; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOCYTOSIS;

EID: 0141574207     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-6-200309160-00009     Document Type: Article

References (26)

1. Modan B. An epidemiological study of polycythemia vera. Blood. 1965;26:657-67. [PMID: 5845783]
2. Modan B, Kallner H, Zemer D, Yoran C. A note on the increased risk of polycythemia vera in Jews. Blood. 1971;37:172-6. [PMID: 5549194]
3. Silverstein MN, Lanier AP. Polycythemia vera, 1935-1969: an epidemiologic survey in Rochester, Minnesota. Mayo Clin Proc. 1971;46:751-3. [PMID: 5128396]
4. Dougan LE, Matthews ML, Armstrong BK. The effect of diagnostic review on the estimated incidence of lymphatic and hematopoietic neoplasms in Western Australia. Cancer. 1981;48:866-72. [PMID: 7248915]
5. Prochazka AV, Markowe HL. The epidemiology of polycythaemia rubra vera in England and Wales 1968-1982. Br J Cancer. 1986;53:59-64. [PMID: 3947516]
6. Chaiter Y, Brenner B, Aghai E, Tatarsky I. High incidence of myeloproliferative disorders in Ashkenazi Jews in northern Israel. Leuk Lymphoma. 1992;7:251-5. [PMID: 1477653]
7. Berglund S, Zettervall O. Incidence of polycythemia vera in a defined population. Eur J Haematol. 1992;48:20-6. [PMID: 1730276]
8. Ania BJ, Suman VJ, Sobell JL, Codd MB, Silverstein MN, Melton LJ 3rd. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989. Am J Hematol. 1994;47:89-93. [PMID: 8092146]
9. Carli PM. Epidemiology of polycythemia vera in Cte d'Or (Burgundy). Nouv Rev Fr Hematol. 1994;36:147-9. [PMID: 8036130]
10. Najean Y, Rain JD, Billotey C. Epidemiological data in polycythaemia vera: a study of 842 cases. Hematol Cell Ther. 1998;40:159-65. [PMID: 9766920]
11. Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol. 1999;61:10-5. [PMID: 10331505]
12. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia. Ann Intern Med. 1995;123:656-64. [PMID: 7574220]
13. Rodeghiero F, Tosetto A. The VITA Project: population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen - relationship with physiological variables and establishment of reference ranges. Thromb Haemost. 1996;76:226-33. [PMID: 8865536]
14. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol. 1996;143:1257-65. [PMID: 8651224]
15. Clayton DG, Hills M. Statistical Models in Epidemiology. Oxford: Oxford Univ Pr; 1993.
16. Fairbanks VF, Tefferi A. Normal ranges for packed cell volume and hemoglobin concentration in adults: relevance to 'apparent polycythemia' [Editorial]. Eur J Haematol. 2000;65:285-96. [PMID: 11092458]
17. Messinezy M, Pearson TC. Apparent polycythaemia: diagnosis, pathogenesis and management. Eur J Haematol. 1993;51:125-31. [PMID: 8405326]
18. Berk PD. Epilogue: broader lessons from the study of polycythemia vera. Semin Hematol. 1997;34:77-80. [PMID: 9025166]
19. Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med. 1995;332:1132-6. [PMID: 7700286]
20. Ruggeri M, Finazzi G, Tosetto A, Riva S, Rodeghiero F, Barbui T. No treatment for low-risk thrombocythaemia: results from a prospective study. Br J Haematol. 1998;103:772-7. [PMID: 9858229]
21. Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol. 1975;12:339-51. [PMID: 1198126]
22. Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol. 1986;23:177-82. [PMID: 3749928]
23. Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol. 1997;34:29-39. [PMID: 9025160]
24. Streiff MB, Smith B, Spivak JL. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Blood. 2002;99:1144-9. [PMID: 11830459]
25. Tefferi A. Diagnosing polycythemia vera: a paradigm shift. Mayo Clin Proc. 1999;74:159-62. [PMID: 10069355]
26. Lengfelder E, Hochhaus A, Kronawitter U, HOche D, Queisser W, Jahn-Eder M, et al. Should a platelet limit of 600 × 10(9)/1 be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br J Haematol. 1998;100:15-23. [PMID: 9450785]